Sexually transmitted diseases in women

Postgraduate Medicine

Volumn 107, Issue 1, 2000, Pages 55-65

  Kirchner, Jeffrey T ^a   Emmert, David H ^b  

^a LANCASTER GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN ETHYLSUCCINATE; FAMCICLOVIR; OFLOXACIN; VALACICLOVIR;

ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; SCREENING; SEXUALLY TRANSMITTED DISEASE;

EID: 0033969311     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.01.815     Document Type: Article

References (31)

1. Gunn RA, Rolfs RT, Greenspan JR, et al. The changing paradigm of sexually transmitted disease control in the era of managed health care. JAMA 1998;279(9):680-4
2. Institute of Medicine Committee on Prevention and Control of Sexually Transmitted Diseases. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC. National Academy Press, 1996
3. Hessol NA, Priddy FH, Bolan G, et al. Management of pelvic inflammatory disease by primary care physicians: a comparison with Centers for Disease Control and Prevention guidelines. Sex Transm Dis 1996;23(2):157-63
4. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1998;47(RR-1):1-111
5. Centers for Disease Control and Prevention. Summary of notifiable diseases. United States, 1997. MMWR 1997;46(54):73
6. Stamm WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis 1999;179(Suppl 2):S380-3
7. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling PF, Mardh PA, et al, eds. Sexually transmitted diseases. 3d ed. New York: McGraw-Hill, 1999:407-19
8. Burstein GR, Gaydos CA, Diener-West M, et al. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998;280(6):521-6
9. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10(1): 160-84
10. Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339(11):739-44
11. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995;345(8944):213-6
12. Howell MR, Quinn TC, Beathwaite W, et al. Screening women for Chlamydia trachomatis in family planning clinics: the cost effectiveness of DNA amplification as-says. Sex Transm Dis 1998;25(2):108-17
13. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies. Ann Inteen Med 1998;128(4):277-84
14. Alvarez-Elcoro S, Enzler MJ. The macrolides, erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc 1999; 74:613-34
15. Wehbeh HA, Ruggeicio RM, Shahem S, et al. Single-dose azithromycin for Chlamydia in pregnant women. J Reprod Med 1998;43(6):509-14
16. Adair CD, Gunter M, Stovall TG, et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998;91(2):165-8
17. Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex virus. Clin Infect Dis 1998;26:541-55
18. Oxman MN. Genital herpes. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. 2d ed. Philadelphia: Saunders, 1998:986-1007
19. Green J, Kocsis A. Psychological factors in recurrent genital herpes. Genitourin Med 1997;73(4):253-6
20. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the Unites States, 1976 to 1994. N Engl J Med 1997;337(16):1105-11
21. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;330:770-5
22. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995;123(11):845-7
23. Whitley RJ, Gnann JW Jr. Acyclovir a decade later. N Engl J Med 1992;327(11): 728-9
24. American College of Obstetricians and Gynecologists. Washington, DC: ACOG. 1998; ACOG Educational Bulletin No. 245:7
25. Wald A, Zeh J, Barnum G, et al. Supression of subclinical shedding of herpes simplex virus type 2 wilh acyclovir. Ann Intern Med 1996;124(2 Pt 1):8-13
26. Reitano M, Tyring S, Lang W, et al. Valacyclovir for the suppresion of recur-rent genital herpes simplex virus infection; a large-scale dose range-finding study. J Infect Dis 1998;178:603-10
27. Díaz-Mitoima F, Sibbald RG, Shafran SD, et al. Oral famiclovit for the suppress-sion of treatment genital herpes. JAMA 1998;180(10):887-92
28. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial. JAMA 1984;251(16): 2103-7
29. Kroon S. Genital herpes - when and how to treat. Semin Dermatol 1990;9(2): 133-40
30. Mertz GJ, Eron L, Kaufman R, et al. Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection. Am J Med 1988; 85(2A):14-9
31. Langenberg AG, Burke RL, Adair SF, et al. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity. Ann Intern Med 1995;122(12):889-98 [Erratum: Ann Intern Med 1995;123(5):395]